DruGeVar

DruGeVar integrates data on drugs, genes, and pharmacogenomic biomarkers associated with regulatory agency-approved medications to link genomic markers to variable drug responses and adverse drug reactions for pharmacogenomic-guided therapy.

Key Features:

• Integration of Pharmacogenomics Data: Consolidates genomic markers correlated with variable drug responses and adverse drug reactions.
• Comprehensive Database Construction: Extracts and integrates information from published literature and online databases to link drugs with their respective genes and pharmacogenomic biomarkers.
• Regulatory-label-focused Curation: Prioritizes pharmacogenomic information present in regulatory agency drug labels.

Scientific Applications:

• Pharmacogenomics Research: Provides curated drug–gene–biomarker associations to support studies of genetic determinants of drug efficacy and toxicity.
• Personalized Medicine: Enables interpretation of pharmacogenomic biomarkers to inform genotype-guided therapeutic decisions that aim to optimize efficacy and reduce adverse effects.

Methodology:

Data extraction and integration from published literature and online databases, with curation focused on regulatory agency-approved drugs that include pharmacogenomic information in their labels.